CTSO
Cytosorbents Corporation
NASDAQ · Healthcare · Medical - Devices · US
$0.35
+0.03%Margins
Gross margin
71.6%
EBITDA margin
-38.0%
EBIT margin
-33.4%
Net margin
-48.9%
FCF margin
-28.0%
2425.2%
Return on equity
-48.0%
Return on assets
-48.5%
Return on invested capital
0.95x
Asset turnover
-$10.3M
Cash from operations
$0.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026